GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
Markets

Monopar Therapeutics rises 5.45% in Tuesday's session

Published by Global Banking & Finance Review

Posted on November 3, 2026

1 min read
Add as preferred source on Google
MNPR 69.89 +5.45% last traded price, 3 Nov 2026
Previous close
66.28
Market cap
—

The figures in this article were checked against this snapshot before publication.

Shares of Monopar Therapeutics in the United States health care sector last traded at 69.89 USD, 5.45% higher than the previous close of 66.28 USD on 3 November 2026.

Last traded price69.89 USD
Previous close66.28 USD
Change from the previous close+5.45%

Prices of Monopar Therapeutics (MNPR), listed in United States, in the currency the stock trades in. The last traded price is the last price the shares changed hands at in the session of 3 November 2026, as reported after the market closed. It is not the exchange's official closing price, and the two can differ. The change compares it with the official close of the previous session, 2 November 2026. We report a stock the day it ends a session 2% or more away from its previous close, where the previous session's trading was worth at least US$5 million. How we compile these reports.

Monopar Therapeutics — daily MNPR Delayed

Related Articles

More from Markets

Explore more articles in the Markets category